Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atopic dermatitis.

Eric L Simpson1, Jon M Hanifin

  • 1Department of Dermatology, Oregon Health and Science University, Portland, OR 97239-3098, USA.

The Medical Clinics of North America
|November 29, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment and Clinical Management of Patients With Atopic Dermatitis Undergoing Patch Testing: Recommendations From an International Electronic Delphi Consensus.

Dermatitis : contact, atopic, occupational, drug·2026
Same author

Defining the Potential for Disease Modification in Atopic Dermatitis.

American journal of clinical dermatology·2026
Same author

Restoring balance in atopic disorders: insights into type 2 immunity and chronic inflammation.

Frontiers in immunology·2026
Same author

Benefit-risk profile comparison between dupilumab and upadacitinib: a structured benefit-risk assessment of the Heads Up trial.

The Journal of dermatological treatment·2026
Same author

Efficacy and Safety of Variable-Dose Versus Continuous-Dose Abrocitinib Treatment in Patients with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis.

Dermatology and therapy·2026
Same author

Long-term benefits of upadacitinib for Atopic Dermatitis: deep responses in patient-reported outcomes over 140 weeks from the Measure Up 1 and Measure Up 2 clinical trials.

The Journal of dermatological treatment·2026
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Atopic dermatitis (AD) is a chronic inflammatory skin condition often starting in childhood. Emerging research suggests AD may predispose individuals to allergies, influencing future treatment and prevention strategies.

Area of Science:

  • Dermatology
  • Immunology
  • Allergy Research

Background:

  • Atopic dermatitis (AD) is a common, itchy, chronic inflammatory skin condition.
  • It frequently co-occurs with asthma and allergic rhinitis, particularly in children.
  • AD prevalence has increased in recent decades, mirroring asthma trends.

Purpose of the Study:

  • To re-evaluate the role of allergy in the causation of atopic dermatitis.
  • To explore the concept of AD as a skin condition that may predispose to allergies.
  • To consider the implications of this perspective on future therapeutic and preventive approaches.

Main Methods:

  • Review of clinical observations and patient histories.
  • Analysis of epidemiological data on AD, asthma, and allergic rhinitis.

Related Experiment Videos

  • Examination of findings from animal studies.

    • Main Results:

    • Documenting allergic causation for AD remains challenging.
    • Evidence increasingly supports AD as a primary skin condition that can lead to allergic sensitization.
    • This paradigm shift is supported by clinical, epidemiological, and animal research.

    Conclusions:

    • Atopic dermatitis is increasingly understood as a skin disease that predisposes to allergies.
    • This revised understanding may significantly alter therapeutic and preventive strategies for atopic diseases.
    • Further research is warranted to fully elucidate the mechanisms and implications.